SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-05-009964
Filing Date
2005-04-01
Accepted
2005-04-01 10:06:55
Documents
6
Period of Report
2005-03-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v015560_8k.txt 8-K 33434
2 v015560_ex10-11.txt EX-10.11 54756
3 v015560_ex10-12.txt EX-10.12 37798
4 v015560_ex10-13.txt EX-10.13 20366
5 v015560_ex10-14.txt EX-10.14 20378
6 v015560_ex10-15.txt EX-10.15 19124
  Complete submission text file 0001144204-05-009964.txt   188119
Mailing Address 36 DERECH BAIT LECHEM JERUSALEM L3 00000
Business Address 36 DERECH BAIT LECHEM JERUSALEM L3 00000 250-519-0553
BRAINSTORM CELL THERAPEUTICS INC (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 912061050 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 333-61610 | Film No.: 05723173
SIC: 2836 Biological Products, (No Diagnostic Substances)